![Duane Dorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Duane Dorn
Director Financiero/CFO en CDx Diagnostics, Inc. .
Cargos activos de Duane Dorn
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Director de Operaciones | 01/04/2020 | - |
Director Financiero/CFO | - | - |
Historial de carrera de Duane Dorn
Formación de Duane Dorn.
St. Bonaventure University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Masters Business Admin | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
CDx Diagnostics, Inc.
![]() CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Duane Dorn
- Experiencia